Balderson, Troy. Thank you very much, and I appreciate your passion with that. My next question is for Dr. Furst. Thank you for being here, ma'am. I often hear that rare disease drug development is limited not by scientific opportunity, but by the difficulty of identifying, enrolling, and retaining patients in clini...